IDbyDNA Beyond COVID-19: Revolutionizing Microbiology through Metagenomics

article image

IDbyDNA is "democratizing" the emerging field of metagenomics by marrying genomic sequencing with state-of-the-art computational sciences to bring rapid, cost-effective precision medicine to infectious disease testing. An example of its potential: rapid characterization of the SARS-CoV-2 virus.

COVID-19 testing has cast an unusual bright spotlight on the obscure world of infectious disease diagnostics, but below the hoopla the broader field of microbiology is undergoing a transformation. Next-generation sequencing, with its enormous power to decipher the intricacies of the microbial genome, is making headway, much the way that technology has already dramatically reshaped oncology, prenatal care, and rare diseases. 

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: